Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 5 Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Hepatoblastoma 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Liver Metastases 1 Colonic Neoplasms 1

Interventions

pembrolizumab 13 Gemcitabine 12 Cyclophosphamide 10 Carboplatin 10 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 Cisplatin 8 Docetaxel 7 X-Rays 6 Filgrastim 6 Doxorubicin 6 Biopsy 6 tislelizumab 5 Radiosurgery 5 Phantoms, Imaging 5 Paclitaxel 5 Nivolumab 5 Irinotecan 5 Bevacizumab 5 130-nm albumin-bound paclitaxel 5 spartalizumab 4 palbociclib 4 Thiotepa 4 Temozolomide 4 Radiotherapy 4 Nuclear Medicine Department, Hospital 4 Mesna 4 Ipilimumab 4 Imatinib Mesylate 4 Ifosfamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Base Sequence × Gastrointestinal × Clear all

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡